Literature DB >> 31727741

Altered allostery of the left flipper domain underlies the weak ATP response of rat P2X5 receptors.

Liang-Fei Sun1, Yan Liu1, Jin Wang1, Li-Dong Huang1, Yang Yang1, Xiao-Yang Cheng1, Ying-Zhe Fan2, Michael X Zhu3, Hong Liang4, Yun Tian5, Heng-Shan Wang6, Chang-Run Guo7, Ye Yu8,5,9.   

Abstract

Although the extracellular ATP-gated cation channel purinergic receptor P2X5 is widely expressed in heart, skeletal muscle, and immune and nervous systems in mammals, little is known about its functions and channel-gating activities. This lack of knowledge is due to P2X5's weak ATP responses in several mammalian species, such as humans, rats, and mice. WT human P2X5 (hP2X5Δ328-349) does not respond to ATP, whereas a full-length variant, hP2X5 (hP2X5-FL), containing exon 10 encoding the second hP2X5 transmembrane domain (TM2), does. However, although rat P2X5 (rP2X5) has a full-length TM2, ATP induces only weak currents in rP2X5, which prompted us to investigate the mechanism underlying this small ATP response. Here, we show that single replacements of specific rP2X5 residues with the corresponding residues in hP2X5 (S191F or F195H) significantly enhance the current amplitude of rP2X5. Using a combination of engineered disulfide cross-linking, single-channel recording, and molecular modeling, we interrogated the effects of S191F and F195H substitutions on the allostery of the left flipper (LF) domain. On the basis of our findings, we propose that the bound ATP-induced distinct allostery of the LF domain with that of other functional subtypes has caused the weak ATP response of rP2X5 receptors. The findings of our study provide the prerequisite for future transgenic studies on the physiological and pathological functions of P2X5 receptors.
© 2019 Sun et al.

Entities:  

Keywords:  ATP-evoked current; ATP-gated ion channel; LF domain; P2X5 receptors; allosteric regulation; conformational change; gating; left flipper domain; molecular dynamics; purinergic receptor

Mesh:

Substances:

Year:  2019        PMID: 31727741      PMCID: PMC6926468          DOI: 10.1074/jbc.RA119.009959

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  A fast, scalable method for the parallel evaluation of distance-limited pairwise particle interactions.

Authors:  David E Shaw
Journal:  J Comput Chem       Date:  2005-10       Impact factor: 3.376

2.  Primary structure and expression of a naturally truncated human P2X ATP receptor subunit from brain and immune system.

Authors:  K T Lê; M Paquet; D Nouel; K Babinski; P Séguéla
Journal:  FEBS Lett       Date:  1997-11-24       Impact factor: 4.124

3.  Intersubunit physical couplings fostered by the left flipper domain facilitate channel opening of P2X4 receptors.

Authors:  Jin Wang; Liang-Fei Sun; Wen-Wen Cui; Wen-Shan Zhao; Xue-Fei Ma; Bin Li; Yan Liu; Yang Yang; You-Min Hu; Li-Dong Huang; Xiao-Yang Cheng; Lingyong Li; Xiang-Yang Lu; Yun Tian; Ye Yu
Journal:  J Biol Chem       Date:  2017-03-16       Impact factor: 5.157

4.  Preferential use of unobstructed lateral portals as the access route to the pore of human ATP-gated ion channels (P2X receptors).

Authors:  Damien S K Samways; Baljit S Khakh; Sébastien Dutertre; Terrance M Egan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-01       Impact factor: 11.205

5.  The nonproton ligand of acid-sensing ion channel 3 activates mollusk-specific FaNaC channels via a mechanism independent of the native FMRFamide peptide.

Authors:  Xiao-Na Yang; You-Ya Niu; Yan Liu; Yang Yang; Jin Wang; Xiao-Yang Cheng; Hong Liang; Heng-Shan Wang; You-Min Hu; Xiang-Yang Lu; Michael X Zhu; Tian-Le Xu; Yun Tian; Ye Yu
Journal:  J Biol Chem       Date:  2017-11-09       Impact factor: 5.157

6.  Genetic and functional analysis of human P2X5 reveals a distinct pattern of exon 10 polymorphism with predominant expression of the nonfunctional receptor isoform.

Authors:  Smita Kotnis; Brendan Bingham; Dmitry V Vasilyev; Scott W Miller; Yuchen Bai; Sarita Yeola; Pranab K Chanda; Mark R Bowlby; Edward J Kaftan; Tarek A Samad; Garth T Whiteside
Journal:  Mol Pharmacol       Date:  2010-03-11       Impact factor: 4.436

7.  Pharmacological and biophysical properties of the human P2X5 receptor.

Authors:  Xuenong Bo; Lin-Hua Jiang; Heather L Wilson; Miran Kim; Geoffrey Burnstock; Annmarie Surprenant; R Alan North
Journal:  Mol Pharmacol       Date:  2003-06       Impact factor: 4.436

Review 8.  Nucleotide signalling during inflammation.

Authors:  Marco Idzko; Davide Ferrari; Holger K Eltzschig
Journal:  Nature       Date:  2014-05-15       Impact factor: 49.962

9.  X-ray structures define human P2X(3) receptor gating cycle and antagonist action.

Authors:  Steven E Mansoor; Wei Lü; Wout Oosterheert; Mrinal Shekhar; Emad Tajkhorshid; Eric Gouaux
Journal:  Nature       Date:  2016-09-14       Impact factor: 49.962

10.  ATP regulates the differentiation of mammalian skeletal muscle by activation of a P2X5 receptor on satellite cells.

Authors:  Mina Ryten; Philip M Dunn; Joseph T Neary; Geoffrey Burnstock
Journal:  J Cell Biol       Date:  2002-07-22       Impact factor: 10.539

View more
  4 in total

Review 1.  Rehabilitation of the P2X5 receptor: a re-evaluation of structure and function.

Authors:  Brian F King
Journal:  Purinergic Signal       Date:  2022-10-24       Impact factor: 3.950

2.  The long β2,3-sheets encoded by redundant sequences play an integral role in the channel function of P2X7 receptors.

Authors:  Xue-Fei Ma; Ting-Ting Wang; Wen-Hui Wang; Li Guan; Chang-Run Guo; Xing-Hua Li; Yun-Tao Lei; Ying-Zhe Fan; Xiao-Na Yang; Motoyuki Hattori; Osamu Nureki; Michael X Zhu; Ye Yu; Yun Tian; Jin Wang
Journal:  J Biol Chem       Date:  2022-04-30       Impact factor: 5.486

Review 3.  Enlightening activation gating in P2X receptors.

Authors:  Christian Sattler; Klaus Benndorf
Journal:  Purinergic Signal       Date:  2022-02-21       Impact factor: 3.950

Review 4.  Update of P2X receptor properties and their pharmacology: IUPHAR Review 30.

Authors:  Peter Illes; Christa E Müller; Kenneth A Jacobson; Thomas Grutter; Annette Nicke; Samuel J Fountain; Charles Kennedy; Günther Schmalzing; Michael F Jarvis; Stanko S Stojilkovic; Brian F King; Francesco Di Virgilio
Journal:  Br J Pharmacol       Date:  2020-12-21       Impact factor: 9.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.